---
schema_version: '1.0'
id: news-20260819-a6291b
title: Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma
url: https://twitter.com/NoubarAfeyan/status/2090050162441752787
url_hash: a6291b992fa380b998c7fbbda0374bfbcdb255a5cb4e185ab0049af628c6c1de
canonical_url: https://twitter.com/NoubarAfeyan/status/2090050162441752787
source: HackerNews
category: news/tech
category_raw: tech
region: usa
tags:
- it_general
- it_tech
- it_ai
lang: en
published_at: '2026-08-19T13:33:35Z'
fetched_at: '2026-08-19T16:17:20.943722Z'
updated_at: '2026-08-19T16:27:23Z'
status: published
content_hash: null
content_changed_at: null
license_note: link-only
summary: null
summary_source: null
summary_en: null
summary_omitted_reason: license_restricted
redistribution: false
keywords_en:
- artificial intelligence
- first
- First_Advantage_Corporation
- for
- Forbes
- it_ai
- it_general
- it_tech
- melanoma
- Moderna
- mRNA
- neoantigen
- Phase
- positive
- reports
- technology
- therapy
- training phases
- Verified Market Reports
entities_en:
- name: First_Advantage_Corporation
  type: organization
- name: Forbes
  type: organization
- name: it_ai
  type: concept
- name: it_general
  type: concept
- name: it_tech
  type: concept
- name: Moderna
  type: organization
- name: training phases
  type: event
- name: Verified Market Reports
  type: content
topics_en:
- artificial intelligence
- technology
numeric_facts: []
entities:
- name: Moderna
  type: organization
- name: Verified Market Reports
  type: content
- name: First_Advantage_Corporation
  type: organization
- name: training phases
  type: event
- name: Forbes
  type: organization
key_facts: []
related: []
related_auto:
- name: DoorDash
  type: organization
  weight: 2.0
- name: Wang Xingxing
  type: person
  weight: 2.0
- name: UberEats
  type: organization
  weight: 1.0
- name: OpenLogi
  type: organization
  weight: 1.0
- name: MacBook Neo
  type: content
  weight: 1.0
computed_at: null
sanitized_at: '2026-08-20T14:56:50.092484+00:00'
---

# Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma

## TL;DR
（要約なし・原文はリンク先を参照 / No summary available; see the source link.）

## Key Points
- it_general / it_tech / it_ai

## Details
(本文なし。リンク先参照)

## Source
元記事: [Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma](https://twitter.com/NoubarAfeyan/status/2090050162441752787) — published 2026-08-19T13:33:35Z